Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic confirmatory study of Pletaal (cilostazol) in vasospastic angina
KCT0001561Phase 3Recruiting
- Sponsor
- Korea Otsuka Pharmaceutical
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in Coronary vasospasm (CAS), sponsored by Korea Otsuka Pharmaceutical. Started Nov 2013; status: recruiting.
02
Drugs
cilostazol
03
Conditions
Coronary vasospasm (CAS)
Beyond the preview
Go deeper on KCT0001561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001561.